- Home
- FSK vs NOVT Comparison
FSK vs NOVT Comparison
Compare FSK & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FSK
- NOVT
- Stock Information
- Founded
- FSK 2007
- NOVT 1968
- Country
- FSK United States
- NOVT United States
- Employees
- FSK N/A
- NOVT N/A
- Industry
- FSK Investment Managers
- NOVT Industrial Machinery/Components
- Sector
- FSK Finance
- NOVT Miscellaneous
- Exchange
- FSK Nasdaq
- NOVT Nasdaq
- Market Cap
- FSK 5.7B
- NOVT 6.0B
- IPO Year
- FSK N/A
- NOVT N/A
- Fundamental
- Price
- FSK $21.54
- NOVT $164.72
- Analyst Decision
- FSK Hold
- NOVT Hold
- Analyst Count
- FSK 9
- NOVT 1
- Target Price
- FSK $19.89
- NOVT $169.00
- AVG Volume (30 Days)
- FSK 1.2M
- NOVT 198.0K
- Earning Date
- FSK 11-06-2024
- NOVT 11-05-2024
- Dividend Yield
- FSK 13.47%
- NOVT N/A
- EPS Growth
- FSK N/A
- NOVT N/A
- EPS
- FSK 1.89
- NOVT 1.66
- Revenue
- FSK $1,761,000,000.00
- NOVT $922,754,000.00
- Revenue This Year
- FSK N/A
- NOVT $10.75
- Revenue Next Year
- FSK N/A
- NOVT $9.68
- P/E Ratio
- FSK $11.42
- NOVT $99.69
- Revenue Growth
- FSK N/A
- NOVT 3.86
- 52 Week Low
- FSK $18.31
- NOVT $142.35
- 52 Week High
- FSK $21.69
- NOVT $187.12
- Technical
- Relative Strength Index (RSI)
- FSK 71.33
- NOVT 38.88
- Support Level
- FSK $20.97
- NOVT $162.40
- Resistance Level
- FSK $21.60
- NOVT $183.85
- Average True Range (ATR)
- FSK 0.26
- NOVT 5.02
- MACD
- FSK 0.06
- NOVT -1.25
- Stochastic Oscillator
- FSK 91.09
- NOVT 35.26
About FSK FS KKR Capital Corp.
FS KKR Capital Corp is a business development company based in the United States. Its portfolio is comprised of investments in senior secured loans and second lien secured loans of private middle market U.S. companies and, to a lesser extent, subordinated loans and certain asset-based financing loans of private U.S. companies. It is focused on providing customized credit solutions to private upper middle-market companies, which it generally defines as companies with annual EBITDA of at least $50 million at the time of investment.
About NOVT Novanta Inc.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in three segments: Precision Medicine and Manufacturing, Medical Solutions, and Robotics and Automation. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.